We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta Appoints Cancer Stem Cell Expert to Scientific Advisory Board

News   Nov 08, 2016

 
Avacta Appoints Cancer Stem Cell Expert to Scientific Advisory Board
 
 
Advertisement
 

RELATED ARTICLES

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

READ MORE

Circulating DNA From Tumor Could Predict Immunotherapy Outcome

News

A newly developed test that detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, according to researchers.

READ MORE

Managing Immune Helper Cells in Elderly Could Improve Vaccine Efficacy

News

Scientists have taken a deeper look at how the immune system changes with age and their findings could help to make flu vaccines much more protective.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE